MAPT and Alzheimer disease: Tau biosensor cells have been used to specifically amplify and quantify minute amounts of bioactive tau from various AD samples including brain extracts using various purification methods, postmortem cerebrospinal fluid (CSF), antemortem lumbar CSF or brain-derived extracellular vesicles [20–24].